As we enter the third quarter of the year, Craig Hemke of Sprott Money and I discuss the outlook for the stock market and precious metals for the coming months. Craig and I discussed the following topics and questions: What I see coming for the S&P 500, Nasdaq, Russell 2000, and the Dow. I am cautiously long in the market;…
The stock market has soared in recent years, with the S&P 500 up by more than 55% since its lowest point in late 2022. But stock prices can’t keep surging forever, and there will be a pullback sooner or later. Around 26% of investors are feeling pessimistic about where the market will be six months from now, according to a July 2024…
Low-priced stocks are attractive as they provide an opportunity to create a diversified portfolio with limited funds. Additionally, there are speculative ideas among low-priced stocks that attracts investors for quick returns at the blink of an eye. There are several interesting stocks under $3 that are likely to trade in double digits before the end of 2025. But a word…
The financial press loves to quote Warren Buffett, and why not? As of this writing, he’s worth $128.4 billion, so he must know what he’s doing. Let’s look at one of Buffett’s key tactics for handling today’s investment climate…a climate that’s bullish but also fraught with a multitude of dangers. Buffett is famous for being a value investor, whereby he…
The long climb back to relevance continues for initial public offerings in the U.S. in 2024, as investors warm up to new publicly traded companies and IPOs are able to back that sentiment up with sturdier returns. So, where do IPOs go from here in the second half of 2024? Sustained high borrowing costs and suspense over a chaotic U.S.…
I had the opportunity to be a guest on the CapitalCosm podcast recently. Danny and I ran through the indicators that are flashing warnings that the stock market and economy are nearing the precipice of a strong downward turn. What Danny and I talked about is: What my high-level view of the market is right now. Of the eleven key…
If you don’t like these 8%, 9% and even 10%+ dividends, well, you’re not really an income investor. That’s right. As I write, select closed-end funds (CEFs) yield 10.6%. Ten. Point. Six. Per. Cent! We contrarians are locking in yields up to nearly 11%. Here’s how, broken down in an 11-step playbook for these 8%, 9%, even 10.6% yields. This…
The agriculture market is expected to experience growth due to shifting consumer preferences toward healthier and diverse diets. Moreover, rising population growth and evolving dietary habits are expected to augment the growth in the agriculture industry. Given the industry’s bright prospects, it could be wise to invest in these fundamentally strong agriculture stocks amid rising food prices. This post originally…
Shares in these three companies have all experienced a significant dip so far in 2024, lagging behind the S&P 500 index’s 14.6% gain over the same period. However, compelling evidence suggests that all three are positioned to outperform the market in the second half and beyond. Here’s why. This post originally appeared at The Motley Fool.
There are multiple reasons to consider exposure to pharmaceutical stocks for the long-term portfolio. First, pharma stocks have a low-beta and provide help in reducing the overall beta of a portfolio that’s overweight growth stocks. Further, pharma stock represents a business that’s relatively immune to economic shocks. At the same time, well established pharma companies have healthy cash flows and therefore…